Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
Open Access
- 21 January 2009
- journal article
- research article
- Published by Wiley in Emergencias
- Vol. 2009 (1), CD001199
- https://doi.org/10.1002/14651858.CD001199.pub2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesisWorld Journal of Gastroenterology, 2008
- Treatment of hepatocellular carcinomaCritical Reviews in Oncology/Hematology, 2006
- Effect of Long-Term Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate after Resection of Hepatitis C Virus-Related Hepatocellular CarcinomaIntervirology, 2005
- Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinomaJournal of Hepatology, 2003
- Neoadjuvant and adjuvant therapy for operable hepatocellular carcinomaPublished by Wiley ,1999
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998
- Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinomaBritish Journal of Surgery, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisalBritish Journal of Surgery, 1995